CURIS INC
جودة البيانات: 100%
CRIS
NASDAQ
Manufacturing
Chemicals
KWD 0.55
▲
KWD 0.05
(9.08%)
القيمة السوقية: 20.39 M
السعر
KWD 0.51
القيمة السوقية
20.39 M
نطاق اليوم
—
نطاق 52 أسبوعًا
—
حجم التداول
—
فتح —
متوسط 50 يوم / 200 يوم
—
متوسط 50 يوم / 200 يوم
—
Quick Summary
النقاط الرئيسية
Revenue declined -2.96% annually over 5 years
Negative free cash flow of -27.20 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 10.47%
النمو
Revenue Growth (5Y)
-2.96%
أقل من متوسط القطاع (1.82%)
Revenue (1Y)-13.43%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
N/A
ROIC-51.31%
Net Margin-80.29%
Op. Margin-60.50%
الأمان
Debt / Equity
N/A
Current Ratio0.70
Interest CoverageN/A
التقييم
PE (TTM|NTM)
-2.69 | -0.52
أقل من متوسط القطاع (-1.49)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Manufacturing (1385 نظير)
مقارنة الأقران
مقابل وسيط قطاع Manufacturing (1385 نظير)| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -2.7 | -1.5 |
| P/B | — | 1.6 |
| ROE % | — | -54.5 |
| Net Margin % | -80.3 | -41.5 |
| Rev Growth 5Y % | -3.0 | 1.8 |
| D/E | — | 0.3 |
السعر المستهدف للمحللين
3 محللين
Buy
الحالي
KWD 0.55
المستهدف
KWD 14.00
KWD 5.00
KWD 17.00
KWD 20.00
التوقعات
مكرر الربحية المستقبلي
-0.52
ربحية السهم المستقبلية
-KWD 0.96
الإيرادات المقدّرة
16.18 M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2027 |
-KWD 0.96
-KWD 1.84 – -KWD 0.24
|
16.18 M | 3 |
| FY2026 |
-KWD 1.15
-KWD 1.80 – -KWD 0.29
|
8.54 M | 3 |
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| 2026 Q2 |
-KWD 0.31
-KWD 0.40 – -KWD 0.21
|
2.20 M | 2 |
| 2026 Q1 |
-KWD 0.29
-KWD 0.39 – -KWD 0.19
|
1.87 M | 2 |
مفاجآت الأرباح
آخر 4 أرباع
| الربع | EPS المقدر | EPS الفعلي | المفاجأة |
|---|---|---|---|
| Q42025 | -KWD 0.43 | -KWD 0.50 | -15.0% |
| Q32025 | -KWD 0.60 | -KWD 0.49 | +18.3% |
| Q22025 | -KWD 1.52 | -KWD 0.68 | +55.1% |
| Q12025 | -KWD 1.26 | -KWD 1.25 | +1.1% |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -13.43% | Revenue Growth (3Y) | -2.94% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -2.96% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 9.44 M | Net Income (TTM) | -7.58 M |
| ROE | N/A | ROA | -26.66% |
| Gross Margin | N/A | Operating Margin | -60.50% |
| Net Margin | -80.29% | Free Cash Flow (TTM) | -27.20 M |
| ROIC | -51.31% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0.70 |
| Interest Coverage | N/A | Asset Turnover | 0.33 |
| Working Capital | -6.01 M | Tangible Book Value | -23.67 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -2.69 | Forward P/E | -0.52 |
| P/B Ratio | N/A | P/S Ratio | 2.16 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 1.26 | Fwd Earnings Yield | N/A |
| FCF Yield | -133.41% | ||
| Market Cap | 20.39 M | Enterprise Value | 11.34 M |
| Per Share | |||
| EPS (Diluted TTM) | -0.58 | Revenue / Share | 0.24 |
| FCF / Share | -0.68 | OCF / Share | -0.68 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 358.76% |
| SBC-Adj. FCF | -31.81 M | Growth Momentum | -10.47 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 9.44 M | 10.91 M | 10.02 M | 10.16 M | 10.65 M |
| Net Income | -7.58 M | -43.39 M | -47.41 M | -56.67 M | -45.44 M |
| EPS (Diluted) | -0.58 | -6.88 | -8.96 | 0.61 | -0.50 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -5.71 M | -44.54 M | -48.33 M | -53.02 M | -42.07 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | — | — | — | — |
| SG&A Expenses | — | — | — | — | — |
| D&A | 169,000.0 | 203,000.0 | 255,000.0 | 233,000.0 | 158,000.0 |
| Interest Expense | — | — | — | — | 0.0 |
| Income Tax | 0.0 | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 19.97 M | 41.27 M | 77.28 M | 108.85 M | 162.30 M |
| Total Liabilities | 14.50 M | 47.26 M | 57.61 M | 62.30 M | 71.59 M |
| Shareholders' Equity | 5.46 M | -6.00 M | 19.67 M | 46.55 M | 90.71 M |
| Total Debt | — | — | — | 900,000.0 | 900,000.0 |
| Cash & Equivalents | 5.06 M | 20.00 M | 26.68 M | 19.66 M | 40.01 M |
| Current Assets | 6.92 M | 26.39 M | 60.91 M | 92.12 M | 122.38 M |
| Current Liabilities | 14.08 M | 19.03 M | 13.52 M | 10.01 M | 13.44 M |
{"event":"ticker_viewed","properties":{"ticker":"CRIS","listing_kind":"stock","pathname":"/stocks/cris","exchange":"NASDAQ","country":"US"}}